发明授权
- 专利标题: Method for detecting novel FGFR4 mutant
- 专利标题(中): 检测新型FGFR4突变体的方法
-
申请号: US14236993申请日: 2012-08-03
-
公开(公告)号: US09267176B2公开(公告)日: 2016-02-23
- 发明人: Takashi Futami , Tatsuya Kawase , Nobuaki Shindou , Rumi Takeshita
- 申请人: Takashi Futami , Tatsuya Kawase , Nobuaki Shindou , Rumi Takeshita
- 申请人地址: JP Tokyo
- 专利权人: Astellas Pharma Inc.
- 当前专利权人: Astellas Pharma Inc.
- 当前专利权人地址: JP Tokyo
- 代理机构: Foley & Lardner LLP
- 优先权: JP2011-171507 20110805
- 国际申请: PCT/JP2012/069869 WO 20120803
- 国际公布: WO2013/021950 WO 20130214
- 主分类号: G01N33/53
- IPC分类号: G01N33/53 ; C12Q1/68
摘要:
[Problem] An object of the present invention is to elucidate a novel genetic mutation which is a cause of cancer, and thereby, to provide a method for detecting the genetic mutation, or a protein which has the mutation, a method for detecting the presence of cancer in a subject, a method for diagnosing cancer in a subject, and a primer set, a probe and a detecting kit for the methods.[Means for Solution] A method for detecting a fibroblast growth factor receptor 4 (FGFR4) mutant in a subject, which comprises a step of detecting the presence of the mutation of glycine at position 183 in a FGFR4 tyrosine kinase domain to cysteine in a sample obtained from the subject.
公开/授权文献
- US20140220035A1 METHOD FOR DETECTING NOVEL FGFR4 MUTANT 公开/授权日:2014-08-07
信息查询
IPC分类: